(no need for a DOGE reengineering here!) Pilots often make things worse during this process
doi: 10.1105/tpc.11.5.781 4 BlaszczykA.BrodzikR.SirkoA
Summary of Key Amylin-Based Therapies in Development (April 2026) Cagrilintide is a long-acting amylin analogue under investigation for obesity management, and the combination of cagrilintide with semaglutide (CagriSema) has demonstrated superior weight loss and metabolic benefits compared with either agent alone or placebo in recent clinical trials
Rather than replacing ergothioneine, astaxanthin may complement the body's existing antioxidant defenses
It represents a significant advance in incretin-based research compounds, with studied effects on insulin secretion, glucagon suppression, gastric emptying, and energy homeostasis modelling in preclinical settings
It corresponds directly with the visible and measurable decline in tissue repair capacity that most people associate with aging: slower wound healing, reduced skin elasticity, thinning hair, and longer recovery times after physical stress